Position: Assistant President
Vice President of Chengdong Campus, SAHZU
Vice Chair of HPB Surgery
Medical School:Zhejiang University School of Medicine, China
Academic Rank:Associate Chief Physician
Surgery and comprehensive therapy of hepatobiliary and pancreatic disease and transplantation, especially in the precise diagnosis and treatment of complicated hepatobiliary and pancreatic tumors
Artificial intelligence in medicine
Liver transplantation, including living donor liver transplantation for children
National High-Level Talents Special Support Program
High-Level Talents Special Support Program of Zhejiang Provience
Medical New Star of Zhejiang Province
First Prize, Zhejiang Science and Technology Advancement Prize
Clinical Top-notch Young Talent, Zhejiang University School of Medicine
Vice Chairman, Youth Committee of Surgery Branch, Zhejiang Medical Association
Vice Chairman, Medical Artificial Intelligence Expert Committee, Chinese Hospital Association
Member, Surgical Oncology Committee, Zhejiang Medical Association
Vice Chairman and Secretary General, Youth Committee of Enhanced Recovery After Surgery Branch, Zhejiang Medical Association
Chairman, Youth Committee of Integrated Oncology Expert Committee, Zhejiang Anti-Cancer Association
Member, Chinese Holistic Integrative Oncology (CHIO), Traditional Chinese and Western Medince Association
Member, Organ Acquisition and Allocation Committee, Chinese Hospital Association
Secretary General, Youth Committee of Enhanced Recovery After Surgery Expert Committee of Surgeons Branch, Chinese Medical Doctor Association
Member and Secretary General, Organ Transplantation Group of Expert Committee of Enhanced Recovery After Surgery, National Health Commission
Secretary, Enhanced Recovery After Surgery Branch, Zhejiang Medical Association
Secretary, Specialist Committee on Enhanced Recovery After Surgery, National Health Council
Member, Enhanced Recovery After Surgery Expert Committee, Chinese Medical Education Association
Member, Expert Committee of Hepatobiliary and Pancreatic MDT, International Hepatobiliary and Pancreatic Society, China Branch
Member, Zhejiang Branch of China Hepatobiliary and Pancreatic Alliance
Member, Youth Committee of Smart Medical Committee, Chinese Medical Doctor Association
Member, Youth Group of Hepatobiliary and Pancreatic Surgery Professional Committee, Cross-Strait Medical and Health Exchange Association
Editorial board member, Journal of Clinical and Translational Hepatology
Editorial board member, Journal of Pancreatology
Editorial board member, Chinese Journal of Hepatobiliary and Pancreatic Surgery
Yang Dua, Xiaohui Qiana, Fenghao Ling, Bingqiang Gao,Weili Wanga, Huang Yangg,?Weilin Wang*,Yuan Ding*. A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation10fen datongxun.Acta Biomaterialia. 2023 Mar 20: S1742-7061(23)00157-5. (IF 10.633)
Jiaojiao Zhang, Bingqiang Gao, Binglin Ye, Zhongquan Sun, Zhefeng Qian, Lisha Yu, Yanli Bi, Lie Ma, Yuan Ding,* Yang Du,* Weilin Wang,* and Zhengwei Mao*. Mitochondrial-Targeted Delivery of Polyphenol-Mediated Antioxidases Complexes against Pyroptosis and Inflammatory Diseases.Adv Mater. 2023 Jan 17: e2208571. (IF 32.086)
Ding Y # , Tong Z # , Jin L # , Ye B, Zhou J * , Sun Z, Yang H, Hong L, Huang F, Wang W * , Mao Z * . An NIR Discrete Metallacycle Constructed from Perylene Bisimide and Tetraphenylethylene Fluorophores for Imaging-Guided Cancer Radio-Chemotherapy. Adv Mater. 2022 Feb;34(7):e2106388. (IF 32.086)
Tong Z # , Guo Q, Xu G, Gao Y,Yang H, Ding Y*, Wang W*, Mao Z*,Supramolecular hydrogel-loaded Prussian blue nanoparticles with photothermal and ROS scavenging ability for tumor postoperative treatments,Composites Part B: Engineering, 2022 (IF 11.322)
Yang H # , Ding Y # , Tong Z, Qian X, Xu H, Lin F, Sheng G * , Hong L, Wang W * , Mao Z * . pH-responsive hybrid platelet membrane-coated nanobomb with deep tumor penetration ability and enhanced cancer thermal/chemodynamic therapy. Theranostics. 2022 May 16;12(9):4250-4268. (IF 11.6)
Ding Y # , Sun Z # , Gao Y # , Zhang S # , Yang C, Qian Z, Jin L, Zhang J, Zeng C, Mao Z * , Wang W * . Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway. Adv Mater. 2021 Aug;33(34):e2102188. (IF 32.086)
Ding Y # , Xu H # , Xu C # , Tong Z # , Zhang S, Bai Y, Chen Y, Xu Q, Zhou L, Ding H, Sun Z, Yan S * , Mao Z * , Wang W * . A Nanomedicine Fabricated from Gold Nanoparticles-Decorated Metal-Organic Framework for Cascade Chemo/Chemodynamic Cancer Therapy. Adv Sci (Weinh). 2020 Jun 14;7(17):2001060. (IF 17.521)
Ding Y # , Sun Z # , Tong Z # , Zhang S, Min J, Xu Q, Zhou L, Mao Z * , Xia H * , Wang W * . Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy. Theranostics. 2020 Apr 6;10(12):5195-5208. (IF 11.6 )
Ding Y # , Zhang S # , Sun Z # , Tong Z # , Ge Y, Zhou L, Xu Q, Zhou H * , Wang W * . Preclinical validation of silibinin/albumin nanoparticles as an applicable system against acute liver injury. Acta Biomater. 2022 Jul 1;146:385-395. (IF: 10.633)
Yang Y # , Ding Y # , Fan B, Wang Y, Mao Z * , Wang W * , Wu J * . Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis. J Control Release. 2020 May 10;321:463-474. (IF: 11.467)
The mechanism and intervention research of NEK2-dependent MDSC metabolic reprogramming and mitochondrial homeostasis regulation in immune escape of liver cancer NEK2, 82272860, General Program of National Natural Science Foundation of China
Study on the mechanism of hepatocyte chemotactic MDSC against ischemia reperfusion injury through YAP-CCL15 pathway, 82001673, National Natural Science Foundation of China
Study on the application of preoperative education system based on mobile streaming media platform in ERAS, Y201840044, scientific research project, Department of Education of Zhejiang Province
The role and mechanism of the comprehensive immune therapy system based on the DC vaccine for HCC in the recurrence of HCC after anti-liver transplantation, 2016KYB083, Medical Health Science and Technology Project, Zhejiang Provincial Health Commission